Page last updated: 2024-11-04

sulfasalazine and Acrodermatitis

sulfasalazine has been researched along with Acrodermatitis in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Acrodermatitis: Inflammation involving the skin of the extremities, especially the hands and feet. Several forms are known, some idiopathic and some hereditary. The infantile form is called Gianotti-Crosti syndrome.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, M1
Zhang, Y1
Xu, H1
Chen, ZQ1
Li, YM1
Jo, SJ1
Park, JY1
Yoon, HS1
Youn, JI1

Other Studies

2 other studies available for sulfasalazine and Acrodermatitis

ArticleYear
A case of acrodermatitis continua of Hallopeau (ACH) successfully treated with sulfasalazine.
    Dermatologic therapy, 2018, Volume: 31, Issue:3

    Topics: Acrodermatitis; Adolescent; Humans; Male; Sulfasalazine

2018
Case of acrodermatitis continua accompanied by psoriatic arthritis.
    The Journal of dermatology, 2006, Volume: 33, Issue:11

    Topics: Acrodermatitis; Administration, Cutaneous; Administration, Oral; Adult; Anti-Inflammatory Agents, No

2006